TCR2 Therapeutics to Present Solid Tumor Data at CAR-TCR Summit and CRI-CIMT-EATI-AACR International Cancer … – Markets Insider
|
TCR2 Therapeutics to Present Solid Tumor Data at CAR-TCR Summit and CRI-CIMT-EATI-AACR International Cancer …
Markets Insider The oral presentations will discuss rationales and mechanisms for its MHC-independent TRuC™-T cells and provide additional preclinical data for TC-210, the company's lead program targeting mesothelin-positive solid tumors including ovarian, pancreatic … |
